The N1'-(p-fluorobenzyl)naltrindole 5 has been synthesized by reaction of 3-O-benzyl NTI 3 with p-fluorobenzylbromide under phase transfer catalysis. The subsequent 3-O-benzyldeprotection of 4 in HBr/CH 3 COOH gave the target compound 5 in three steps from naltrindole 2. p-FBNTI 5 is a novel delta o
Synthesis and 124I-labeling of m-iodophenylpyrrolomorphinan as a potential PET imaging agent for delta opioid (DOP) receptors
✍ Scribed by Eyup Akgün; Philip S. Portoghese; Munawwar Sajjad; Hani A. Nabi
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- French
- Weight
- 119 KB
- Volume
- 50
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Condensation of phenylazo‐β‐ketoamide 4 with oxymorphone 5 afforded an m‐iodophenylpyrrolomorphinan (m‐IPPM) 6 mediated by elemental zinc in acetic acid/sodium acetate buffer. m‐IPPM 6 is a novel opioid receptor agonist (K~i~ = 4.53 nM for DOP) with high selectivity for DOP receptors. m‐IPPM 6 was converted into the positron emitter m‐[^124^I]PPM 8 via the stannylated intermediate 7. The final yield was 24.5 ± 1.9 % (n = 6) with a specific activity of 2.5 ± 1.2 Ci/µmol. Copyright © 2007 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract __N__‐4‐(4‐chlorophenyl)butyl‐__N__,__N__‐diethyl‐7‐[^18^F]fluoroheptylammonium ([^18^F]‐fluoroclofilium) has been prepared as a potential cardiac imaging agent. For the synthesis of this radiolabelled ammonium salt, its tosyloxylated analogue was prepared as a precursor, and the non‐ra
## Abstract The preparation and synthesis of [^125^I]7α‐O‐iodoallyl diprenorphine, a high affinity opioid receptor antagonist, is described using a versatile vinylstannane as prosthetic group for radioiodination at the tertiary alcohol group in the 7α‐side chain. Radioiododestannylation with select
## Abstract A major drawback of conventionally radioiodinated monoclonal antibodies for radioimmunotherapy is __in vivo__ dehalogenation of iodine as a result of deiodinase recognition. To solve this problem we have synthesized a YYK tri‐peptide consisting of non‐metabolizable D‐amino acids modifie